Jump to content

Propallorphan

From Wikipedia, the free encyclopedia

Propallorphan
Clinical data
ATC code
  • none
Identifiers
  • (1R,9R,10R)-17-prop-2-ynyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol
PubChem CID
ChEMBL
Chemical and physical data
FormulaC19H23NO
Molar mass281.399 g·mol−1
3D model (JSmol)
  • C#CCN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)O
  • InChI=1S/C19H23NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h1,6-7,13,16,18,21H,3-5,8-12H2/t16-,18+,19+/m0/s1
  • Key:OKICQDFBWUMTDE-QXAKKESOSA-N

Propallorphan also known by numerous code names, some of the most prominent being RO-1-7780 (RO-7780) and NIH 6045, MCL-117 is an experimental drug of the substituted morphinan family that acts as an opioid antagonist.

Pharmacology

[edit]

Pharmacodynamics

[edit]

Propallorphan has long been studied as an opioid (i.e., narcotic) antagonist, as confirmed by a 1956 study in which it was first described as RO-1-7780 and was shown to antagonize alphaprodine or morphine in dogs, and alphaprodine in humans. Simultaneous administration of RO-1-7780 with alphaprodine at a dose of 1/75 or 1/100 of the latter appeared to completely reverse the respiratory depression induced in dogs by the narcotic alone. At the same dose ratios of RO-1-7780 to alphaprodine in humans, the antagonist reduced the severity of alphaprodine-induced respiratory depression, while the overall narcotic effect was otherwise considered unchanged.[1] Furthermore, a 1962 study reports that RO-1-7780 reverses the respiratory depressant effects of codeine, although twice the dose is required to achieve the same effect as levallorphan.[2]

In a 1966 study, it was investigated alongside the known opioid antagonist nalorphine as a supplement to thiopental and nitrous oxide anesthesia. RO-1-7780 did not produce the marked respiratory depression observed following morphine administered in the same manner and at the same dose of 1.0 mg/kg.[3] Propallorphan is much weaker in analgesia than the related compound levorphanol; its analgesic activity showed an EC50 of 38.9 mg/kg, with a duration of effect of 226 minutes.[4] Propallorphan acts as a hallucinogen, as evidenced by the fact that its levorotatory isomer induces dysphoria and hallucinations—indeed, producing dysphoric and hallucinogenic effects comparable in intensity to those of nalorphine.[5][6]

References

[edit]
  1. ↑ Marcus PS, Megirian R, White CW (July 1956). "RO-1-7780, a potent antagonist of alphaprodine". Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine. 92 (3). New York, N.Y.: SAGE Publications: 512–515. doi:10.3181/00379727-92-22528. PMID 13359450.
  2. ↑ Anand Rao D, Hofmann H (1962-01-01). "Influence of (-)3-hydroxy-N-propargyl-morphinan on the respiratory depressant action of codeine". Experientia. 18 (1): 7–8. doi:10.1007/BF02136626. ISSN 0014-4754.
  3. ↑ Keats AS, Telford J (January 1966). "Studies of analgesic drugs. X. Respiratory effects of narcotic antagonists". The Journal of Pharmacology and Experimental Therapeutics. 151 (1): 126–132. doi:10.1016/s0022-3565(25)27235-4. PMID 5902169.
  4. ↑ Eddy NB, Halbach H, Braenden OJ (1956). "Synthetic substances with morphine-like effect; relationship between analgesic action and addiction liability, with a discussion of the chemical structure of addiction-producing substances". Bulletin of the World Health Organization. 14 (3): 353–402. PMC 2538049. PMID 13342924.
  5. ↑ Musacchio JM, Klein M, Canoll PD (1989). "Dextromethorphan and sigma ligands: common sites but diverse effects". Life Sciences. 45 (19): 1721–1732. doi:10.1016/0024-3205(89)90510-9. PMID 2556614.
  6. ↑ Musacchio JM (June 1990). "The psychotomimetic effects of opiates and the sigma receptor". Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 3 (3): 191–200. PMID 2163646.